Cargando…

Feasibility of quantitative sensory testing in juvenile idiopathic arthritis

OBJECTIVE: Juvenile Idiopathic Arthritis (JIA) is a childhood-rheumatic disease with pain as a major early complaint, and in 10–17% pain remains a major symptom. Very few data exist on sensory threshold changes at the knee in JIA, a location in which inflammation often manifests. We determined wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mensink, Maarten O., Eijkelkamp, Niels, Veldhuijzen, Dieuwke S., Wulffraat, Nico M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364560/ https://www.ncbi.nlm.nih.gov/pubmed/35945540 http://dx.doi.org/10.1186/s12969-022-00715-5

Ejemplares similares

Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
por: Smits, Rosanne M., et al.
Publicado: (2020)

Pain hypersensitivity in juvenile idiopathic arthritis: a quantitative sensory testing study
por: Cornelissen, Laura, et al.
Publicado: (2014)

Early predictors of prognosis in juvenile idiopathic arthritis patients: a systematic literature review
por: Van Dijkhuizen, Pieter, et al.
Publicado: (2014)

Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
por: Ćalasan, Maja Bulatović, et al.
Publicado: (2012)

Pain sensitivity in young adults with juvenile idiopathic arthritis: a quantitative sensory testing study
por: Arnstad, Ellen Dalen, et al.
Publicado: (2020)

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
por: Bulatović, Maja, et al.
Publicado: (2011)

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
por: Swart, Joost F, et al.
Publicado: (2018)

What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
por: Swart, Joost F, et al.
Publicado: (2013)

Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review
por: Van Dijkhuizen, Pieter, et al.
Publicado: (2014)

Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review
por: van Dijkhuizen, EH Pieter, et al.
Publicado: (2014)

Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?
por: Schoemaker, Casper G., et al.
Publicado: (2020)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
por: Van Dijkhuizen, EH Pieter, et al.
Publicado: (2011)

Challenging the silent temporomandibular joint paradigm in children with juvenile idiopathic arthritis
por: de Sonnaville, Willemijn F. C., et al.
Publicado: (2022)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
por: Van Dijkhuizen, Pieter E H, et al.
Publicado: (2011)

Identifying disrupted biological factors and patient-tailored interventions for chronic fatigue in adolescents and young adults with Q-Fever Fatigue Syndrome, Chronic Fatigue Syndrome and Juvenile Idiopathic Arthritis (QFS-study): study protocol for a randomized controlled trial with single-subject experimental case series design
por: Vroegindeweij, Anouk, et al.
Publicado: (2022)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
por: Heijstek, MW, et al.
Publicado: (2008)

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
por: Swart, JF, et al.
Publicado: (2013)

Patient’s experiences with the care for juvenile idiopathic arthritis across Europe
por: van Dijkhuizen, E. H. Pieter., et al.
Publicado: (2018)

A three minute- screening tool for temporomandibular joint involvement in children with juvenile idiopathic arthritis
por: Giancane, Gabriella, et al.
Publicado: (2014)

Monitoring patients with juvenile idiopathic arthritis using health-related quality of life
por: Doeleman, Martijn J. H., et al.
Publicado: (2021)

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
por: van Pelt, Philomien A, et al.
Publicado: (2012)

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
por: van Pelt, Philomine A, et al.
Publicado: (2012)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists
por: Armbrust, Wineke, et al.
Publicado: (2013)

Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study
por: van Dijkhuizen, Evert Hendrik Pieter, et al.
Publicado: (2015)

Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis
por: Kip, Michelle M A, et al.
Publicado: (2022)

Costs of Hospital‐Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System
por: Kip, Michelle M. A., et al.
Publicado: (2022)

Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients
por: Swart, Joost F, et al.
Publicado: (2019)

Temporomandibular joint involvement in Juvenile Idiopathic Arthritis: reliability and validity of a screening protocol for the rheumatologist
por: Steenks, Michel H, et al.
Publicado: (2015)

Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis
por: Grazziotin, Luiza R., et al.
Publicado: (2022)

Cross-Cultural Adaptation and Validation of the Methotrexate Intolerance Severity Score Questionnaire in Portuguese (Brazil) for Children and Adolescents with Juvenile Idiopathic Arthritis
por: Londe, Ana Carolina, et al.
Publicado: (2023)

Juvenile idiopathic arthritis
por: Bhatt, Krupa H, et al.
Publicado: (2014)

Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Reliability and measurement error of anterior maximum voluntary bite force in children with juvenile idiopathic arthritis and healthy children
por: de Sonnaville, Willemijn F. C., et al.
Publicado: (2023)

Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review
por: Kip, Michelle M. A., et al.
Publicado: (2019)

Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
por: Boom, V., et al.
Publicado: (2015)

PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis
por: Vastert, S, et al.
Publicado: (2013)

Increasing feasibility and patient comfort of MRI in children with juvenile idiopathic arthritis
por: Hemke, Robert, et al.
Publicado: (2012)

Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry
por: van Straalen, Joeri W., et al.
Publicado: (2022)

Fatigue in patients with Juvenile Idiopathic Arthritis: relationship to perceived health, physical health, self-efficacy, and participation
por: Armbrust, Wineke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2m99pccd9fqkhucshq59bfsbm0